Bridges Investment Counsel’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$2.46M Sell
23,548
-535
-2% -$60.4K 1.36% 20
2017
Q3
$3.51M Sell
24,083
-53,393
-69% -$7.27M 1.95% 14
2017
Q2
$10.1M Buy
77,476
+32,943
+74% +$4.04M 2.29% 5
2017
Q1
$5.54M Sell
44,533
-31,951
-42% -$3.82M 1.62% 13
2016
Q4
$8.85M Sell
76,484
-3,606
-5% -$402K 2.15% 7
2016
Q3
$8.37M Buy
80,090
+120
+0.2% +$13K 1.76% 12
2016
Q2
$7.89M Buy
79,970
+2,630
+3% +$272K 1.73% 13
2016
Q1
$7.74M Sell
77,340
-35,171
-31% -$3.62M 1.67% 12
2015
Q4
$13M Hold
112,511
2.26% 11
2015
Q3
$13M Buy
112,511
+39,666
+54% +$4.92M 2.26% 11
2015
Q2
$8.43M Buy
72,845
+3,260
+5% +$373K 1.98% 10
2015
Q1
$8.02M Buy
69,585
+815
+1% +$97.4K 1.83% 11
2014
Q4
$7.69M Sell
68,770
-110
-0.2% -$11.6K 1.76% 12
2014
Q3
$6.53M Buy
68,880
+220
+0.3% +$19.9K 1.5% 18
2014
Q2
$5.9M Sell
68,660
-1,250
-2% -$95.1K 1.35% 24
2014
Q1
$4.88M Buy
69,910
+1,780
+3% +$141K 1.14% 30
2013
Q4
$5.76M Buy
68,130
+360
+0.5% +$28.5K 1.32% 25
2013
Q3
$5.22M Sell
67,770
-1,800
-3% -$126K 1.3% 24
2013
Q2
$4.07M Buy
+69,570
New +$4.19M 1.05% 30

Other funds holding CELG

Bridges Investment Counsel's CELG Position: Q4 2017 in Review

Bridges Investment Counsel reduced its Celgene Corp (CELG) stake by 2.2% in Q4 2017, selling an estimated $60.4K and leaving 23,548 shares worth $2.46M. The position accounts for 1.36% of the portfolio, ranked #20.

Bridges Investment Counsel first reported a position in CELG in Q2 2013 and has held it in 19 quarters since. The position peaked at $13M in Q4 2015. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Bridges Investment Counsel held 23,548 shares of Celgene Corp worth $2.46M as of Q4 2017.
  • Bridges Investment Counsel sold 535 Celgene Corp shares in Q4 2017, an estimated $60.4K.
  • Celgene Corp made up 1.36% of Bridges Investment Counsel's portfolio in Q4 2017, its #20 holding.
  • Bridges Investment Counsel first reported a position in Celgene Corp in Q2 2013 and has held it in 19 quarters since.
  • Bridges Investment Counsel's Celgene Corp position peaked at $13M in Q4 2015.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Bridges Investment Counsel's 13F filing for Q4 2017, filed 9 Feb 2018.